Stock listing
NASDAQ:ZNTL Zentalis Pharmaceuticals, Inc. Stock
Home listing (NASDAQ) of Zentalis Pharmaceuticals, Inc.
Follow Zentalis Pharmaceuticals, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:ZNTL
$1.78 USD -0.07 (-3.8%)
Close on Nov 3, 2026
- Day range
- $1.75 – $1.96 USDNov 3, 2026
- Volume
- 1.27M sharesNov 3, 2026
- Market cap
- $174.7M USDAt the close on Nov 3, 2026 · price × 98.12M shares outstanding
- 52-week range
- $1.21 – $6.95 USDLowest and highest trades, Nov 4, 2025 – Nov 3, 2026
- Traded on an average day
- $3.67M USDMedian day 993,240 shares · last 3 months, Aug 3, 2026 – Nov 3, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:ZNTL · Home | $1.78 USD | -0.07 (-3.8%) | 1,271,091 | $1.84 | $1.96 | $1.745 | $1.85 | Close on Nov 3, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Nov 3, 2026 · NASDAQ:ZNTL · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $1.78 | -0.07 | -3.8% | $1.84 | $1.96 | $1.745 | 1,271,091 | |
| $1.85 | -0.11 | -5.6% | $1.95 | $1.99 | $1.83 | 889,758 | |
| $1.96 | -0.03 | -1.5% | $1.99 | $1.99 | $1.86 | 1,332,472 | |
| $1.99 | -0.07 | -3.4% | $2.06 | $2.11 | $1.97 | 1,446,156 | |
| $2.06 | +0.08 | +4.0% | $2.008 | $2.095 | $1.98 | 2,204,705 | |
| $1.98 | -0.09 | -4.3% | $2.07 | $2.118 | $1.96 | 1,721,943 | |
| $2.07 | -0.14 | -6.3% | $2.21 | $2.215 | $2.03 | 1,044,257 | |
| $2.21 | -0.20 | -8.3% | $2.41 | $2.41 | $2.18 | 947,100 | |
| $2.41 | +0.05 | +2.1% | $2.33 | $2.43 | $2.29 | 745,800 | |
| $2.36 | -0.03 | -1.3% | $2.36 | $2.47 | $2.34 | 1,207,000 | |
| $2.39 | +0.09 | +3.9% | $2.31 | $2.44 | $2.25 | 1,557,100 | |
| $2.30 | +0.17 | +8.0% | $2.33 | $2.356 | $2.07 | 2,736,400 | |
| $2.13 | -0.11 | -4.9% | $2.25 | $2.30 | $2.10 | 1,101,800 | |
| $2.24 | -0.08 | -3.4% | $2.27 | $2.396 | $2.21 | 2,034,800 | |
| $2.32 | -0.08 | -3.3% | $2.44 | $2.45 | $2.30 | 865,300 | |
| $2.40 | -0.12 | -4.8% | $2.53 | $2.54 | $2.39 | 570,100 | |
| $2.52 | -0.12 | -4.5% | $2.64 | $2.64 | $2.51 | 546,100 | |
| $2.64 | +0.13 | +5.2% | $2.56 | $2.659 | $2.511 | 612,400 | |
| $2.51 | -0.04 | -1.6% | $2.51 | $2.535 | $2.39 | 1,272,400 | |
| $2.55 | -0.12 | -4.5% | $2.63 | $2.68 | $2.54 | 820,100 | |
| $2.67 | -0.11 | -4.0% | $2.81 | $2.82 | $2.65 | 827,600 | |
| $2.78 | +0.26 | +10.3% | $2.69 | $2.84 | $2.63 | 2,994,700 | |
| $2.52 | -0.085 | -3.3% | $2.64 | $2.65 | $2.495 | 1,451,200 | |
| $2.605 | -0.165 | -6.0% | $2.74 | $2.78 | $2.58 | 1,898,700 | |
| $2.77 | +0.055 | +2.0% | $2.71 | $2.795 | $2.605 | 1,011,500 | |
| $2.715 | +0.115 | +4.4% | $2.62 | $2.81 | $2.57 | 4,779,700 | |
| $2.60 | -0.10 | -3.7% | $2.70 | $2.70 | $2.57 | 1,273,600 | |
| $2.70 | -0.05 | -1.8% | $2.75 | $2.77 | $2.65 | 1,067,400 | |
| $2.75 | -0.12 | -4.2% | $2.84 | $2.89 | $2.73 | 1,173,900 | |
| $2.87 | -0.21 | -6.8% | $3.07 | $3.09 | $2.78 | 1,451,000 | |
| $3.08 | +0.05 | +1.7% | $3.07 | $3.14 | $3.01 | 956,300 | |
| $3.03 | -0.08 | -2.6% | $3.15 | $3.15 | $2.995 | 675,300 | |
| $3.11 | +0.03 | +1.0% | $3.07 | $3.18 | $2.99 | 1,259,700 | |
| $3.08 | -0.02 | -0.6% | $3.18 | $3.215 | $3.02 | 1,088,500 | |
| $3.10 | -0.03 | -1.0% | $3.23 | $3.26 | $3.035 | 1,225,800 | |
| $3.13 | -0.37 | -10.6% | $3.51 | $3.51 | $3.12 | 1,398,600 | |
| $3.50 | -0.01 | -0.3% | $3.47 | $3.57 | $3.44 | 750,400 | |
| $3.51 | -0.08 | -2.2% | $3.63 | $3.67 | $3.465 | 787,700 | |
| $3.59 | -0.21 | -5.5% | $3.74 | $3.765 | $3.555 | 863,100 | |
| $3.80 | -0.23 | -5.7% | $3.99 | $4.039 | $3.79 | 780,400 | |
| $4.03 | +0.04 | +1.0% | $4.00 | $4.10 | $3.885 | 519,200 | |
| $3.99 | -0.12 | -2.9% | $4.05 | $4.185 | $3.92 | 997,800 | |
| $4.11 | +0.34 | +9.0% | $3.80 | $4.12 | $3.73 | 1,366,500 | |
| $3.77 | +0.06 | +1.6% | $3.68 | $3.88 | $3.68 | 897,800 | |
| $3.71 | -0.05 | -1.3% | $3.68 | $3.74 | $3.55 | 863,800 | |
| $3.76 | -0.04 | -1.1% | $3.79 | $3.79 | $3.67 | 471,800 | |
| $3.80 | -0.08 | -2.1% | $3.88 | $3.89 | $3.72 | 695,400 | |
| $3.88 | -0.01 | -0.3% | $3.87 | $3.92 | $3.82 | 430,100 | |
| $3.89 | +0.01 | +0.3% | $3.87 | $3.93 | $3.83 | 576,200 | |
| $3.88 | +0.12 | +3.2% | $3.78 | $3.89 | $3.78 | 799,148 | |
| $3.76 | -0.065 | -1.7% | $3.84 | $3.96 | $3.75 | 988,680 | |
| $3.825 | -0.015 | -0.4% | $3.95 | $3.95 | $3.815 | 740,800 | |
| $3.84 | +0.02 | +0.5% | $4.015 | $4.04 | $3.78 | 1,570,900 | |
| $3.82 | +0.14 | +3.8% | $3.76 | $3.86 | $3.66 | 1,780,300 | |
| $3.68 | -0.025 | -0.7% | $3.75 | $3.86 | $3.58 | 1,201,400 | |
| $3.705 | +0.145 | +4.1% | $3.56 | $3.845 | $3.54 | 1,571,600 | |
| $3.56 | -0.59 | -14.2% | $3.53 | $3.70 | $3.49 | 4,575,200 | |
| $4.15 | -0.14 | -3.3% | $4.29 | $4.42 | $4.135 | 820,200 | |
| $4.29 | +0.18 | +4.4% | $4.13 | $4.31 | $4.08 | 559,000 | |
| $4.11 | -0.04 | -1.0% | $4.19 | $4.24 | $4.03 | 401,800 | |
| $4.15 | -0.07 | -1.7% | $4.20 | $4.28 | $4.04 | 824,800 | |
| $4.22 | -0.78 | -15.6% | $4.68 | $4.826 | $4.01 | 1,578,300 | |
| $5.00 | +0.05 | +1.0% | $4.92 | $5.15 | $4.92 | 701,400 | |
| $4.95 | +0.07 | +1.4% | $4.91 | $4.955 | $4.78 | 578,300 | |
| $4.88 | +0.23 | +4.9% | $4.67 | $4.89 | $4.67 | 788,700 | |
| $4.65 | -0.09 | -1.9% | $4.79 | $4.89 | $4.619 | 820,500 |
- Ticker
- NASDAQ:ZNTL
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Nov 3, 2026
Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences
Latest deck · August 2026
Investor Presentation (August 2026)
Investor deck · 29 slides
Latest news
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Nov 2, 2026
Closed $1.78 (-3.8%) on Nov 3, 2026
Zentalis Pharmaceuticals Announces Meaningful Median Overall Survival Data in Cyclin E1-Positive Platinum-Resistant Ovarian Cancer from DENALI Part 1b to be Presented at the ESMO Congress 2026
Oct 23, 2026
Closed $2.21 (-8.3%) on Oct 23, 2026
Zentalis Pharmaceuticals Announces First Overall Survival Data for Azenosertib from DENALI Part 1b Published in ESMO Congress 2026 Abstract
Oct 18, 2026
Closed $2.30 (+8.0%) on Oct 19, 2026
Zentalis Pharmaceuticals Announces Closing of Underwritten Public Offering, Including Full Exercise of Underwriters' Option to Purchase Additional Shares
Aug 18, 2026
Closed $3.68 (-0.7%) on Aug 18, 2026
Zentalis Pharmaceuticals Announces Pricing of Underwritten Public Offering
Aug 13, 2026
Closed $3.56 (-14.2%) on Aug 14, 2026
Zentalis Pharmaceuticals Announces Proposed Underwritten Public Offering
Aug 13, 2026
Closed $3.56 (-14.2%) on Aug 14, 2026
Zentalis Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Updates
Aug 6, 2026
Closed $4.22 (-15.6%) on Aug 7, 2026
Zentalis Pharmaceuticals to Present at the European Society for Medical Oncology (ESMO) Congress 2026
Jul 17, 2026
Closed $5.01 (-2.0%) on Jul 20, 2026
Financings
Public offering of common stock
Aug 18, 2026
Closed: US$92.6M raised · US$3.5 a share · TD Cowen +4
Dealers: TD Cowen (co-lead), Guggenheim Securities (co-lead), Oppenheimer & Co. (co-lead), H.C. Wainwright & Co., Rodman & Renshaw LLC
Use of proceeds: Fund clinical trials, preclinical studies, regulatory filings, manufacturing, companion diagnostic, pre-commercial activities, working capital and general purposes
Announced Aug 13, 2026 · Update Aug 14, 2026 · Closed Aug 17, 2026 · Closed Aug 18, 2026
Decks
Investor Presentation (August 2026)
Investor deck · 29 slides · August 2026
Investor Presentation (May 2026)
Investor deck · 29 slides · May 12, 2026
Investor Presentation (April 2026)
Investor deck · 39 slides · Apr 9, 2026
Investor Presentation (January 2026)
Investor deck · 40 slides · Jan 9, 2026
Zentalis Pharmaceuticals, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 24 in the last 12 months · 114 in all · newest Nov 3, 2026 · oldest 2020
- Decks
- 23 decks · latest August 2026
Where Zentalis Pharmaceuticals, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:ZNTL · Home listing · This page | NASDAQ | United States | USD |
| BOATS:ZNTL | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Zentalis Pharmaceuticals, Inc.